Avalyn Pharma Inc. (Investor Relations) / GlobeNewswireMay 1, 2026IPO filing
Avalyn Pharma announced the closing of its initial public offering on May 1, 2026, selling 19,166,667 shares at the $18.00 IPO price, including full exercise of the underwriters’ overallotment option to purchase an additional 2,500,000 shares.